Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans

Journal of Neural Transmission

Volumn 111, Issue 4, 2004, Pages 537-545

  Damberg, M ^a,c   Berggard C ^a   Farde, L ^b   Sedvall, G C ^b   Jonsson E G ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

AP 2; Cerebrospinal fluid; Dopamine; Gene expression; PET; Serotonin

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE 2 RECEPTOR; HOMOVANILLIC ACID; MONOAMINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; FEMALE; GENOTYPE; HUMAN; MALE; METABOLITE; MONOAMINE METABOLISM; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADULT; ANALYSIS OF VARIANCE; AUTORADIOGRAPHY; BIOGENIC AMINES; CORPUS STRIATUM; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SWEDEN; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRITIUM;

EID: 1842728417     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-003-0097-4     Document Type: Article

References (44)

1. Amin FDM, Davis KL (1992) Homovanillic acid measurement in clinical research: a review of methodology. Schizophr Bull 18: 123-148
2. Boularand S, Darmon MC, Ravassard P, Mallet J (1995) Characterization of the human tryptophan hydroxylase gene promoter. Transcriptional regulation by cAMP requires a new motif distinct from the cAMP-responsive element. J Biol Chem 270: 3757-3764
3. Bradley CC, Blakely RD (1997) Alternative splicing of the human serotonin transporter gene. J Neurochem 69: 1356-1367
4. Bream JH, Carrington M, O'Toole S, Dean M, Gerrard B, Shin HD, Kosack D, Modi W, Young HA, Smith MW (2000) Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 51: 50-58
5. Chazaud C, Oulad-Abdelghani M, Bouillet P, Decimo D, Chambon P, Dolle P (1996) AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 54: 83-94
6. Cohen (1988) Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey
7. Damberg M, Garpenstrand H, Berggard C, Åsberg M, Hallman J, Oreland L (2000a) The genotype of human transcription factor AP-2beta is associated with platelet monoamine oxidase B activity. Neurosci Lett 291: 204-206
8. Damberg M, Garpenstrand H, Alfredsson J, Ekblom J, Forslund K, Rylander G, Oreland L (2000b) A polymorphic region in the human transcription factor AP-2beta gene is associated with specific personality traits. Mol Psychiatry 5: 220-224
9. Damberg M, Garpenstrand H, Hallman J, Oreland L (2001a) Genetic mechanisms of behavior-don't forget about the transcription factors. Mol Psychiatry 6: 503-510
10. Damberg M, Eller M, Tõnissaar M, Oreland L, Harro J (2001b) Levels of transcription factors AP-2alpha and AP-2beta in the brainstem are correlated to monoamine turnover in the rat forebrain. Neurosci Lett 313: 102-104
11. Damberg M, Berggård C, Mattila-Evenden M, Rylander G, Forslund K, Garpenstrand H, Bergman H, Gustavsson JP, Jönsson EG (2003) Transcription factor AP-2b genotype associated to anxiety-related personality traits in women - a replication study. Neuropsychobiology 48: 169-175
12. Du YL, Wilcox BD, Teitler M, Jeffrey JJ (1994) Isolation and characterization of the rat 5-hydroxytryptamine type 2 receptor promoter: constitutive and inducible activity in myometrial smooth muscle cells. Mol Pharmacol 45: 1125-1131
13. Erdfelder E, Buchner A (1996) GPower: a general power analysis program. Behav Res Methods Instruments Comput 28: 1-11
14. 11C]raclopride. Arch Gen Psychiatry 47: 213-219
15. 11C]raclopride in man. Synapse 20: 200-208
16. Garelis EST (1973) Sites of origin in the central nervous system of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 36: 625-629
17. Geijer T, Rydberg U, Gyllander A, Jönsson EG, Sedvall G, Valverius P, Terenius L (1994) Dopamine D2 receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244: 26-32
18. Greco D, Zellmer E, Zhang Z, Lewis E (1995) Transcription factor AP-2 regulates expression of the dopamine beta-hydroxylase gene. J Neurochem 65: 510-516
19. Hahn SL, Hahn M, Kang UJ, Joh TH (1993) Structure of the rat aromatic L-amino acid decarboxylase gene: evidence for an alternative promoter usage. J Neurochem 60: 1058-1064
20. Jönsson EG, Sedvall G, Brene S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA (1996) Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 40: 1032-1043
21. Jönsson EG, Goldman D, Spurlock G, Gustavsson JP, Nielsen DA, Linnoila M, Owen MJ, Sedvall GC (1997) Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur Arch Psychiatry Clin Neurosci 247: 297-302
22. Jönsson EG, Nothen MM, Grunhage F, Farde L, Nakashima Y, Propping P, Sedvall GC (1999) Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4: 290-296
23. Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC (2000) A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 34: 239-244
24. Jönsson EG, Damberg M, Forslund K, Mattila-Evenden M, Rylander G, Åsberg M, Oreland L, Sedvall GC (2002) No association between a transcription factor Activating Protein 2beta (AP-2beta) gene variant and schizophrenia. Neurosci Lett 330: 290-292
25. Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC (2003) Dopamine D2 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Am J Med Genet 119B: 28-34
26. Kim HS, Hong SJ, LeDoux MS, Kim KS (2001) Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2. J Neurochem 76: 280-294
27. Kopin IJ, Jimerson DC, Polinsky RJ (1983) Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol. Science 219: 73-75
28. Leeman J (1983) The striatal cholinergic interneuron: synaptic target of dopaminergic terminals. Neuroscience 10: 1105-1120
29. McMahon A, Kvetnansky R, Fukuhara K, Weise VK, Kopin IJ, Sabban EL (1992) Regulation of tyrosine hydroxylase and dopamine beta-hydroxylase mRNA levels in rat adrenals by a single and repeated immobilization stress. J Neurochem 58: 2124-2130
30. Minowa T, Mouradian MM (1992) Analysis of the promoter region of the rat D2 dopamine receptor gene. Biochemistry 31: 8389-8396
31. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 5: 105-119
32. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, Sinowatz F, Hofstadter F, Schule R, Buettner R (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2beta. Development 121: 2779-2788
33. Moser M, Pscherer A, Roth C, Becker J, Mucher G, Zerres K, Dixkens C, Weis J, Guay-Woodford L, Buettner R, Fassler R (1997) Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. Genes Dev 11: 1938-1948
34. Müller MM, Gerster T, Schaffner W (1988) Enhancer sequences and the regulation of gene transcription. Eur J Biochem 176: 485-495
35. Nordströ AL, Farde L, Halldin C (1992) Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol. Psychopharmacology (Berl) 106: 433-438
36. 11C]raclopride binding in healthy young adults and schizophrenic patients-reliability and age effects. Hum Psychopharmacol 7: 157-165
37. Philipp J, Mitchell PJ, Malipiero U, Fontana A (1994) Cell type-specific regulation of expression of transcription factor AP-2 in neuroectodermal cells. Dev Biol 165: 602-614
38. Scheinin M (1985) Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity. Med Biol 63: 1-17
39. Sedvall G, Fyro B, Gullberg B, Nyback H, Wiesel FA, Wode-Helgodt B (1980) Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry 136: 366-374
40. Swahn C-G, Wiesel F-A, Sedvall G (1976) Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmenographic method. Psychopharmacology (Berl) 48: 147-152
41. Takeuchi S, Waragi M, Roth C, Kanazawa I, Buettner R, Mouradian MM, Okazawa H (1999) AP-2beta represses D(1A) dopamine receptor gene transcription in neuro2a cells. Brain Res Mol Brain Res 74: 208-216
42. Williams T, Tjian R (1991) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev 5: 670-682
43. Williams T, Admon A, Luscher B, Tjian R (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2: 1557-1569
44. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD (2001) Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 276: 40755-40760